Our Network AstraZeneca unveils latest research at ESC Congress 2024, showcasing strength of its cardiovascular, renal and metabolism portfolio and pipeline Tags: #Research #ESMO #AstraZeneca #Cardiovascular #Renal #Metabolism New data demonstrate the connection between heart failure and transthyretin-mediated amyloid cardiomyopathy, underscoring the need for earlier detection and diagnosis.
